EMEA-002427-PIP01-18-M02
EMEA-002427-PIP01-18-M02
EMEA-002427-PIP01-18-M02
Opinion/decision on a Paediatric investigation plan (PIP): Zynrelef, bupivacaine,meloxicam (HTX-011), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pain, PIP number: P/0160/2023
EMEA-002233-PIP01-17-M02
EMEA-002166-PIP01-17-M07
Opinion/decision on a Paediatric investigation plan (PIP): Odefsey, emtricitabine,rilpivirine,tenofovir alafenamide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infectious diseases, PIP number: P/0193/2023
Opinion/decision on a Paediatric investigation plan (PIP): Reagila, Cariprazine (hydrochloride), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Psychiatry, PIP number: P/0162/2023
Sodium salicylate (poultry other than turkey): European Public MRL Assessment Report (EPMAR) - CVMP
Clinical Trials Information System (CTIS) sponsor end user training programme - November 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 25 November 2024, 09:00 (CET) to 28 November 2024, 13:30 (CET)
Clinical Trials Information System (CTIS) sponsor end user training programme - October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 28 October 2024, 14:00 (CET) to 31 October 2024, 18:30 (CET)
Clinical Trials Information System (CTIS) sponsor end user training programme - September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 September 2024, 09:00 (CEST) to 26 September 2024, 13:30 (CEST)